Lack of association between α1-antichymotrypsin polymorphism and late-onset depressive disorder

Psychiatry Research

Volumn 88, Issue 3, 1999, Pages 221-226

  Ohara, Koichi ^a   Suzuki, Yasuo ^a   Yoshida, Katsuaki ^a   Terada, Hiroshi ^a   Ohara, Kenshiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Antichymotrypsin; Dementia; Depression; Late onset; Polymorphism

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADOLESCENT; ADULT; ARTICLE; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; AGED; ALLELE; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; JAPAN; MIDDLE AGED; ONSET AGE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0033233150     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00093-1     Document Type: Article

References (24)

1. Alexopoulos G.S., Meyers B.S., Young R.C., Mattis S., Kakuma T. The course of geriatric depression with 'reversible dementia': a controlled study. American Journal of Psychiatry. 150:1993;1693-1699.
2. Endicott J., Spitzer R.L. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry. 35:1978;837-844.
3. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 12:1975;189-198.
4. Folstein S.E., Abbott M.H., Chase G.A., Jensen B.A., Folstein M.F. The association of affective disorder with Huntington's disease in a case series and in families. Psychological Medicine. 13:1983;537-542.
5. 1-antichymotrypsin in Alzheimer disease. Genomics. 33:1996;53-56.
6. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 23:1960;56-62.
7. Heidrich A., Thome J., Rösler M., Baumer A. Apolipoprotein E ε-4 allele frequency in late-onset depression. Biological Psychiatry. 41:1997;912.
8. Itabashi S., Arai H., Matsui T., Matsushita S., Muramatsu T., Higuchi S., Trojanowski J.Q., Sasaki H. Absence of association of alpha(1)-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases. Experimental Neurology. 151:1998;237-240.
9. Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APO*E4-associated Alzheimer's disease risk is modified by (1-antichymotrypsin polymorphism. Nature Genetics. 10:1995;486-488.
10. Knesper D.J. The depressions of Alzheimer's disease: sorting, pharmacotherapy, and clinical advice. Journal of Geriatric Psychiatry and Neurology. 8(Suppl. 1):1995;S40-S51.
11. Krishnan K.R.R., Goli V., Ellinwood E.H., France R.D., Blazer D.G., Nemeroff C.B. Leukoencephalopathy in patients diagnosed as major depressive. Biological Psychiatry. 23:1988;519-522.
12. Krishnan K.R.R., Hays J.C., Tupler L.A., George L.K., Blazer D.G. Clinical and phenomenological comparisons of late-onset and early-onset depression. American Journal of Psychiatry. 152:1995;785-788.
13. Krishnan K.R.R., Tupler L.A., Ritchie J.C. Jr., McDonald W.M., Knight D.L., Nemeroff C.B., Carroll B.J. Apolipoprotein E- ε 4 frequency in geriatric depression. Biological Psychiatry. 40:1996;69-71.
14. Krishnan K.R.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. American Journal of Psychiatry. 154:1997;497-501.
15. Lesser I.M., Miller B.L., Boone K.B. Brain imaging and cognitive function in late-onset psychotic depression. Journal of Neuropsychiatry. 3:1991;33-40.
16. Liston E.H. Jr. Occult presenile dementia. Journal of Nervous and Mental Disease. 164:1977;263-267.
17. Marriam A.E., Aronson M.K., Gaston P., Wey S.L., Katz I. The psychiatric symptoms of Alzheimer's disease. Journal of the American Geriatric Society. 36:1988;7-12.
18. Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology. 31:1981;645-650.
19. Mendlewicz J., Baron M. Morbidity risks in subtypes of unipolar depressive illness: differences between early and late onset forms. British Journal of Psychiatry. 139:1981;463-466.
20. Ohara K., Nagai M., Suzuki Y., Yoshida K., Tsukamoto T., Ohara K. Apolipoprotein E ε 4 allele and Japanese late-onset depressive disorder. Biological Psychiatry. 44:1998;550-554.
21. Robinson R.G., Kubos K.L., Starr L.B., Rao K., Price T.R. Mood changes in stroke patients: relationship to lesion location. Comprehensive Psychiatry. 24:1983;555-566.
22. Wang L., Hirayasu K., Ishizawa M., Kobayashi Y. Purification of Genomic DNA from human whole blood by isopropanol-fractionation with concentrated NaI and SDS. Nucleic Acids Research. 22:1994;1774-1775.
23. Wenham P.R., Price W.H., Blundell G. Apolipoprotein E genotyping by one stage PCR. Lancet. 337:1991;1158-1159.
24. World Health Organization, 1993. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO, Geneva.